Conrad F. Mir
Executive Director of Business Development
Mr. Mir brings over 20 years of corporate finance, investment banking, investor relations and executive management experience. He joined the Company in November 2008. Prior to joining Advaxis, Mr. Mir was the CEO and president of Aran Laboratories, a super-oxygen technology company; communications executive for Roche AG (OTCQX: RHHBY) in the Xenical group; equity research analyst for First Liberty Investment Group, a regional broker dealer, and fixed income/CMO trader for Nomura Securities International, a global investment banking institution. He holds a BA in Economics and English from New York University with concentrations in Mathematics and Physics. He is a member of the National Investor Relations Institute (NIRI).
